# Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States

> **NCT00875641** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 390659 (actual)

## Conditions studied

- Infections, Rotavirus

## Interventions

- **OTHER:** Health Insurance Database

## Key facts

- **NCT ID:** NCT00875641
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-20
- **Primary completion:** 2016-11-04
- **Final completion:** 2016-11-04
- **Target enrollment:** 390659 (ACTUAL)
- **Last updated:** 2019-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00875641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00875641, "Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00875641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*